Genetic Analysis AS: IPO prior to listing was significantly oversubscribed

Pressmeddelande

Genetic Analysis AS: IPO prior to listing was significantly oversubscribed

OSLO, NORWAY - 15 September 2021: On 13 September 2021, the subscription period in Genetic Analysis AS (“GA” or “the Company”) issue of units (“the IPO”) prior to the planned listing on Spotlight Stock Market (“Spotlight”) ended. The IPO targeted NOK 60 million, of which NOK 48 million were pre-subscribed. Total subscriptions amounted to approximately NOK 99 million, corresponding to a subscription ratio of approximately 165 percent.

An extraordinary general meeting on 20 September 2021 will formally decide on the IPO. The Company will thus receive approximately NOK 60 million before issue costs amounting to approximately NOK 5.4 million. Through the IPO, the Company will receive approximately 1200 new shareholders. The first day of trading in Genetic Analysis on Spotlight Stock Market is expected to be on 1 October 2021.

CEO Ronny Hermansen comments

"We would like to thank everyone who participated in the IPO, and we are very grateful for the strong interest in GA, as shown in this funding. GA has initiated a growth plan for the coming years, and with the support of the IPO, we will be able to expand the commercialization of the current product portfolio within IBS / IBD in the EU and the US. Based on the competitive advantages that a standardized clinical diagnostic platform will have in the microbiota field, compared to the current research-based tools, and the huge number of potential patients, we assess that the market and the opportunities for Genetic Analysis technology is significant.”

Subscription and allocation

The IPO was subscribed for a total of approximately NOK 99 million, including pre-subscription commitments, corresponding to a subscription ratio of approximately 165 percent. GA will be provided approximately NOK 60 million before issue costs, which are estimated to amount to approximately NOK 5.4 million. Through the IPO, GA will add approximately 1200 new shareholders.

The Board has conditionally decided on the allocation of units in advance of an extraordinary general meeting on 20 September 2021, in accordance with the principles stated in the prospectus. Subscribers who have been allocated units in the issue will have payments for the allocated amount drawn from their accounts on 16 September 2021.

First trading day

The first day of trading is dependent on the Norwegian Companies Registration Office's registration of the capital increase. The first day of trading in GA shares and warrants of series TO 1 and TO 2 on Spotlight is scheduled for 1 October 2021. The share will be traded under the short name/ticker code “GEAN” and the share's ISIN code is NO0010692130, warrants of series TO 1 will be traded under the short name “GEAN TO 1”, ISIN code NO0011054223 and warrants of series TO 2 will be traded under the short name “GEAN TO 2”, ISIN code NO0011054231.

Financial advisor, legal advisor and issuing agent

Sedermera Fondkommission is the Swedish financial advisor and Advokatfirmaet Wiersholm AS is the Norwegian legal advisor to GA in connection with the IPO and listing. DNB Bank ASA acts as Issuing Agent.

For more information about the IPO and the planned listing, please contact:

Sedermera Fondkommission
Phone: +46 (0) 40 615 14 10
E-mail: info@sedermera.se


 

This disclosure contains information that Genetic Analysis AS is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 15.09.2021.

Bifogade filer

2021-09-15 GA Press Release - Oversubscribed IPOhttps://mb.cision.com/Main/20846/3415998/1468805.pdf

Tips – Börskollens nyhetsbrev och aktieapp!

Nyhetsbrev: Varje vecka handplockar vi de mest läsvärda av tusentals nyheter från våra flöden och varvar med exklusiva intervjuer och tävlingar. Starta gratis prenumeration!

Aktieapp: Skapa bolagsbevakningar för dina favoritbolag och få automatiska pushnotiser vid aktienyheter och bolagshändelser. Ladda ner vår gratis app!

Läses av andra just nu

Tips från oss på Börskollen

Här tipsar vi om tjänster som vi på Börskollen själva använder och kan stå bakom. Därutöver rekommenderar vi också att du prenumererar på vårt nyhetsbrev samt laddar ner vår app (helt gratis). Texten nedan innehåller annonslänkar och investeringar är alltid förenade med risk.

Investera enkelt och billigt i aktier och fonder

Hos Avanza kan du kostnadsfritt öppna konto för att kunna handla aktier. För att investera i fonder så billigt som möjligt tycker vi dock att du ska spana in SAVR där du kan äga över 1 300 av de bästa fonderna och betala 30-50 % mindre i avgifter, varje år!

Ett tips är att öppna konto hos båda för att nyttja fördelarna och de låga avgifterna hos respektive aktör.

Sänk dina månadskostnader och öka din sparkvot

När det kommer till tråkiga utgifter som försäkringar kan vi verkligen rekommendera Hedvig. Vi jämförde direkt på deras site och sänkte vår egen kostnad för hemförsäkring med 2 436 kr per år, jämfört med det näst billigaste alternativet. Pengar som nu läggs på sparande istället.

Analysera dina favoritaktier med marknadens bästa tjänster

För dig som är nyfiken på teknisk eller fundamental analys tipsar vi om analystjänsterna TradingView och Börsdata. Plattformarna går att använda helt gratis och är annars väldigt prisvärda om du vill ha fler funktioner. Vi skulle inte klara oss utan dessa fantastiska tjänster!